GlassScriptPhysician profile
Paul M Spezia
NPI 1588776140
$6,041.89
in general payments reported to CMS, 2019-2025
15 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $865 · 2021: $525 · 2022: $1,648 · 2023: $217 · 2024: $14.47 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,282 · Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,282.06 |
| Food and Beverage | $578.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,092.93 | 2020-2025 | |
| Arthrex, INC. | $1,424.29 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $480.72 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $330.77 | 2020-2023 | Xiaflex |
| Microport Orthopedics INC | $294.43 | 2021-2025 | Mpo Medial Pivot Knee |
| Pacira Therapeutics, INC. | $145.03 | 2019-2021 | |
| Radius Health, INC. | $55.79 | 2020-2022 | |
| Organogenesis INC. | $51.13 | 2023 | Puraply |
| Ethicon US, LLC | $38.26 | 2022 | |
| Amgen INC. | $31.21 | 2022-2023 | Evenity, Prolia |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Solventum Corporation | $21.24 | 2025 | Prevena |
| Smith+Nephew, INC. | $16.94 | 2025 | Pico |
| Alvogen INC | $15.68 | 2023 | Teriparatide |
| Molnlycke Health Care US, LLC | $14.47 | 2024 | Avance, Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Spezia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.